Michael E. Rosenfeld

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

Seppo Ylä‐Herttuala, Wulf Palinski, Michael E. Rosenfeld et al. · Journal of Clinical Investigation · 1989 · 1.9K citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Low density lipoprotein undergoes oxidative modification in vivo.

Wulf Palinski, Michael E. Rosenfeld, Seppo Ylä‐Herttuala et al. · Proceedings of the National Academy of Sciences · 1989 · 1.5K citations · Full text

Life Sciences, Biochemistry, Pathobiology +17

A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis

Herbert C. Stary, A. Bleakley Chandler, Robert E. Dinsmore et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1995 · 952 citations

Medicine, Cardiology, Pathology +12

Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.

Seppo Ylä‐Herttuala, Beth Lipton, Michael E. Rosenfeld et al. · Proceedings of the National Academy of Sciences · 1991 · 877 citations

Life Sciences, Cell Biology, Molecular Biology +11

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

Wulf Palinski, Seppo Ylä‐Herttuala, Michael E. Rosenfeld et al. · Arteriosclerosis An Official Journal of the American Heart Association Inc · 1990 · 618 citations · Full text

Life Sciences, Biochemistry, Immunology +17